Drug Type Small molecule drug |
Synonyms SKL PSY, SKL-PSY/FZ-016 |
Target |
Action modulators |
Mechanism 5-HT1A receptor modulators(Serotonin 1a (5-HT1a) receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
RegulationSpecial Review Project (China) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Depressive Disorder | Phase 1 | China | 02 Aug 2019 | |
Bipolar Disorder | Phase 1 | United States | - | - |
Bipolar Disorder | Phase 1 | China | - | |
Bipolar Disorder | Phase 1 | China | - | |
Bipolar Disorder | Phase 1 | - | - | |
Anxiety Disorders | Preclinical | South Korea | - |